Ambros Therapeutics
- Biotech or pharma, therapeutic R&D
Ambros is a clinical-stage biotech company currently operating in "stealth"mode. Our lead program is in global phase 3 development for a rare metabolic bone disease that results in significant pain and disability.
We are interested in additional in-licensing opportunities for IND-ready / clinical-stage programs in development across the following therapeutic areas: rare diseases, pain, bone, inflammation and autoimmune. We are also open to exploring other compelling programs that may not exactly fit these criteria.
Address
IrvineCalifornia
United States
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}